Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Fourth Left Atrial Appendage Occlusion Study (LAAOS-4)

NCT05963698 is registered in ClinicalTrials.gov with Hamilton Health Sciences Corporation as lead sponsor.

NCT NCT05963698
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05963698 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Fourth Left Atrial Appendage Occlusion Study (LAAOS-4)
Lead sponsor
Hamilton Health Sciences Corporation
Phase
Not applicable
Overall status
Recruiting
Start date
November 30, 2023
Completion date
December 1, 2029
Enrollment
4,000 (estimated)
Sites
150

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation, stroke, ischemic, systemic embolism